Invivyd Inc

XNAS:IVVD 4:00:00 PM EDT

1.10

-0.01 (-0.90%)

7:47:08 PM EDT: $1.14 +0.04 (+3.64%)

Market Cap (Intraday)	321.15M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$14.4 Million
Adjusted EPS	-$0.11

See more estimates

10-Day MA	$1.18
50-Day MA	$1.43
200-Day MA	$1.67

See more pivots

Invivyd Inc Stock, XNAS:IVVD

1601 Trapelo Road, Suite 178, Waltham, Massachusetts 02451

United States of America

Phone: +1.781.819.0080

Number of Employees: 99

http://invivyd.com

Description

Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.